THE BEST SIDE OF GW280264X

Notwithstanding several setbacks, quite a few MDM2 inhibitors have now progressed into late-phase clinical improvement. New approaches have also been formulated to reinforce the efficacy of MDM2 inhibitors also to mitigate their on-goal toxicity. In this critique, we summarize the progress and difficulties in the development of the MDM2 qualified t